Protein arginine methylation: from enigmatic functions to therapeutic targeting

Q Wu, M Schapira, CH Arrowsmith… - Nature reviews Drug …, 2021 - nature.com
Protein arginine methyltransferases (PRMTs) are emerging as attractive therapeutic targets.
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …

The regulation, functions and clinical relevance of arginine methylation

E Guccione, S Richard - Nature reviews Molecular cell biology, 2019 - nature.com
Methylation of arginine residues by protein arginine methyltransferases (PRMTs) is involved
in the regulation of fundamental cellular processes, including transcription, RNA processing …

Protein arginine methyltransferases: promising targets for cancer therapy

JW Hwang, Y Cho, GU Bae, SN Kim… - Experimental & molecular …, 2021 - nature.com
Protein methylation, a post-translational modification (PTM), is observed in a wide variety of
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …

Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy

S Biswas, CM Rao - European journal of pharmacology, 2018 - Elsevier
Addition of chemical tags on the DNA and modification of histone proteins impart a distinct
feature on chromatin architecture. With the advancement in scientific research, the key …

PRMTs and arginine methylation: cancer's best-kept secret?

J Jarrold, CC Davies - Trends in molecular medicine, 2019 - cell.com
Post-translational modification (PTM) of proteins is vital for increasing proteome diversity
and maintaining cellular homeostasis. If the writing, reading, and removal of modifications …

Development of potent and selective coactivator-associated arginine methyltransferase 1 (CARM1) degraders

H Xie, MS Bacabac, M Ma, EJ Kim… - Journal of Medicinal …, 2023 - ACS Publications
CARM1 is amplified or overexpressed in many cancer types, and its overexpression
correlates with poor prognosis. Potent small-molecule inhibitors for CARM1 have been …

The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer

G Gao, S Hausmann, NM Flores, AM Benitez… - Nature …, 2023 - nature.com
The coactivator associated arginine methyltransferase (CARM1) promotes transcription, as
its name implies. It does so by modifying histones and chromatin bound proteins. We …

CARM1/PRMT4: making its mark beyond its function as a transcriptional coactivator

S Suresh, S Huard, T Dubois - Trends in cell biology, 2021 - cell.com
Coactivator-associated arginine methyltransferase 1 (CARM1), identified 20 years ago as a
coregulator of transcription, is an enzyme that catalyzes arginine methylation of proteins …

[HTML][HTML] Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance

Y Zhu, T Xia, DQ Chen, X Xiong, L Shi, Y Zuo… - Drug Resistance …, 2024 - Elsevier
Drug resistance remains a major challenge in cancer treatment, necessitating the
development of novel strategies to overcome it. Protein arginine methyltransferases …

CARM1 regulates replication fork speed and stress response by stimulating PARP1

MM Genois, JP Gagné, T Yasuhara, J Jackson… - Molecular cell, 2021 - cell.com
DNA replication forks use multiple mechanisms to deal with replication stress, but how the
choice of mechanisms is made is still poorly understood. Here, we show that CARM1 …